What Wall St. Knows About Canopy Growth Today.

Small-cap Health Care company Canopy Growth has logged a 1.1% change today on a trading volume of 1,775,509. The average volume for the stock is 7,433,390.

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. Based in Smiths Falls, Canada the company has 3,151 full time employees and a market cap of $905,705,600.

The company is now trading -7.57% away from its average analyst target price of $1.98 per share. The 5 analysts following the stock have set target prices ranging from $1.0 to $3.32, and on average give Canopy Growth a rating of underperform.

Over the last year, CGC shares have gone down by -7726.0%, which represents a difference of -6355.0% when compared to the S&P 500. The stock's 52 week high is $8.64 per share and its 52 week low is $1.81. With its gross margins declining an average -67.2% over the last four years, Canopy Growth may not have a strong enough business to reverse this trend.

Date Reported Revenue ($ k) Cost of Revenue ($ k) Gross Margins (%) YoY Growth (%)
2022-03-31 520,325 713,379 -37.1 -402.86
2021-03-31 546,649 479,689 12.25 254.09
2020-03-31 398,772 430,456 -7.95 -120.23
2019-03-31 226,341 137,411 39.29 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.